Patent Application
20200230601
As the field of microfluidics continues to progress, microfluidic devices have become convenient platforms for processing and manipulating micro-objects such as biological cells. Some embodiments of the present invention are directed to improvements in microfluidic devices and methods of operating microfluidic devices.
In some embodiments of the invention, a microfluidic device can include a flow region and a microfluidic sequestration pen. The flow region can be configured to contain a flow of a first fluidic medium. The microfluidic sequestration pen can include an isolation structure and a connection region. The isolation structure can comprise an isolation region configured to contain a second fluidic medium. The connection region can fluidically connect the isolation region to the flow region so that, while the flow region and the microfluidic sequestration pen are substantially filled with fluidic media: components of the second medium are able to diffuse into the first medium or components of the first medium are able to diffuse into the second medium; and there is substantially no flow of the first medium from the flow region into the isolation region.
Some embodiments of the invention include a process of analyzing a biological micro-object in a microfluidic device, which can comprise a microfluidic channel to which at least one microfluidic sequestration pen is fluidically connected. The at least one sequestration pen can comprise a fluidic isolation structure comprising an isolation region and a connection region fluidically connecting the isolation region to the channel. The process can include loading one or more biological micro-objects into the at least one sequestration pen, and incubating the loaded biological micro-objects for a period of time sufficient to allow the biological micro-objects to produce an analyte of interest. The process can also include disposing capture micro-objects in the channel adjacent to an opening from the connection region of the at least one sequestration pen to the channel, and monitoring binding of the capture micro-objects to the analyte of interest. The capture micro-objects can comprise at least one type of affinity agent capable of specifically binding the analyte of interest.
This specification describes exemplary embodiments and applications of the invention. The invention, however, is not limited to these exemplary embodiments and applications or to the manner in which the exemplary embodiments and applications operate or are described herein. Moreover, the Figures may show simplified or partial views, and the dimensions of elements in the Figures may be exaggerated or otherwise not in proportion for clarity. In addition, as the terms “on,” “attached to,” or “coupled to” are used herein, one element (e.g., a material, a layer, a substrate, etc.) can be “on,” “attached to,” or “coupled to” another element regardless of whether the one element is directly on, attached, or coupled to the other element or there are one or more intervening elements between the one element and the other element. Also, directions (e.g., above, below, top, bottom, side, up, down, under, over, upper, lower, horizontal, vertical, “x,” “y,” “z,” etc.), if provided, are relative and provided solely by way of example and for ease of illustration and discussion and not by way of limitation. In addition, where reference is made to a list of elements (e.g., elements a, b, c), such reference is intended to include any one of the listed elements by itself, any combination of less than all of the listed elements, and/or a combination of all of the listed elements.
As used herein, “substantially” means sufficient to work for the intended purpose. The term “ones” means more than one.
As used herein, the term “micro-object” can encompass one or more of the following: inanimate micro-objects such as microparticles, microbeads (e.g., polystyrene beads, Luminex™ beads, or the like), magnetic beads, microrods, microwires, quantum dots, and the like; biological micro-objects such as cells (e.g., embryos, oocytes, sperms, cells dissociated from a tissue, blood cells, hydridomas, cultured cells, cells from a cell line, cancer cells, infected cells, transfected and/or transformed cells, reporter cells, and the like), liposomes (e.g, synthetic or derived from membrane preparations), lipid nanorafts, and the like; or a combination of inanimate micro-objects and biological micro-objects (e.g., microbeads attached to cells, liposome-coated micro-beads, liposome-coated magnetic beads, or the like). Lipid nanorafts have been described, e.g., in Ritchie et al. (2009) “Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs,” Methods Enzymol., 464:211-231.
As used herein, the term “cell” refers to a biological cell, which can be a plant cell, an animal cell (e.g., a mammalian cell), a bacterial cell, a fungal cell, or the like. An animal cell can be, for example, from a human, a mouse, a rat, a horse, a goat, a sheep, a cow, a primate, or the like.
A “component” of a fluidic medium is any chemical or biochemical molecule present in the medium, including solvent molecules, ions, small molecules, antibiotics, nucleotides and nucleosides, nucleic acids, amino acids, peptides, proteins, sugars, carbohydrates, lipids, fatty acids, cholesterol, metabolites, or the like.
As used herein in reference to a fluidic medium, “diffuse” and “diffusion” refer to thermodynamic movement of a component of the fluidic medium down a concentration gradient.
The phrase “flow of a medium” means bulk movement of a fluidic medium primarily due to any mechanism other than diffusion. For example, flow of a medium can involve movement of the fluidic medium from one point to another point due to a pressure differential between the points. Such flow can include a continuous, pulsed, periodic, random, intermittent, or reciprocating flow of the liquid, or any combination thereof. When one fluidic medium flows into another fluidic medium, turbulence and mixing of the media can result.
The phrase “substantially no flow” refers to a rate of flow of a fluidic medium that is less than the rate of diffusion of components of a material (e.g., an analyte of interest) into or within the fluidic medium. The rate of diffusion of components of such a material can depend on, for example, temperature, the size of the components, and the strength of interactions between the components and the fluidic medium.
As used herein in reference to different regions within a microfluidic device, the phrase “fluidically connected” means that, when the different regions are substantially filled with fluid, such as fluidic media, the fluid in each of the regions is connected so as to form a single body of fluid. This does not mean that the fluids (or fluidic media) in the different regions are necessarily identical in composition. Rather, the fluids in different fluidically connected regions of a microfluidic device can have different compositions (e.g., different concentrations of solutes, such as proteins, carbohydrates, ions, or other molecules) which are in flux as solutes move down their respective concentration gradients and/or fluids flow through the device.
In some embodiments, a microfluidic device can comprise “swept” regions and “unswept” regions. An unswept region can be fluidically connected to a swept region, provided the fluidic connections are structured to enable diffusion but substantially no flow of media between the swept region and the unswept region. The microfluidic device can thus be structured to substantially isolate an unswept region from a flow of medium in a swept region, while enabling substantially only diffusive fluidic communication between the swept region and the unswept region.
The capability of biological micro-objects (e.g., biological cells) to produce specific biological materials can be assayed in such a microfluidic device. For example, sample material comprising biological micro-objects to be assayed for production of an analyte of interest can be loaded into a swept region of the microfluidic device. Ones of the biological micro-objects can be selected for particular characteristics and disposed in unswept regions. The remaining sample material can then be flowed out of the swept region and an assay material flowed into the swept region. Because the selected biological micro-objects are in unswept regions, the selected biological micro-objects are not substantially affected by the flowing out of the remaining sample material or the flowing in of the assay material. The selected biological micro-objects can be allowed to produce the analyte of interest, which can diffuse from the unswept regions into the swept region, where the analyte of interest can react with the assay material to produce localized detectable reactions, each of which can be correlated to a particular unswept region. Any unswept region associated with a detected reaction can be analyzed to determine which, if any, of the biological micro-objects in the unswept region are sufficient producers of the analyte of interest.
As shown in
The process 100 can then proceed to step 108, where the process 100 can perform a subsequent test on the initial group of micro-objects. The subsequent test performed at step 108 can be different than the first test performed at step 104. For example, the subsequent test can test for a subsequent characteristic that is different than the first characteristic tested at step 104. As another example, the subsequent test performed at step 108 can test for the same characteristic as step 104 (the first characteristic mentioned above), but the subsequent test can have a different sensitivity, accuracy, precision, or the like. For example, the subsequent test performed at step 108 can be more sensitive to the first characteristic than the first test performed at step 104. Regardless, at step 110, the process 100 can separate the micro-objects that test positive to the subsequent test at step 108 from the micro-objects that test negative to the subsequent test.
If the first test of step 104 and the subsequent test of step 108 test for the same characteristic, after steps 108 and 110, micro-objects that tested positive for that characteristic (the first characteristic referred to above in the discussion of step 104) in response to two different tests have been separated from the k mixtures of micro-objects loaded into the microfluidic device at k performances of step 102. As shown, steps 108 and 110 can be repeated, and at each repetition, the process 100 can apply a different subsequent test at step 108 that tests for the same characteristic. Indeed, steps 108 and 110 can be repeated n times after which the process 100 has sorted from the k mixtures of micro-objects loaded into the microfluidic device at step 102 micro-objects that have tested positive n+1 times for the first characteristic tested at steps 104 and 108. The number n can be any integer that is one or greater.
As noted, the process 100 can alternatively test at step 108 for a subsequent characteristic that is different than the first characteristic tested at step 104. In such an embodiment, micro-objects having both the first characteristic and the subsequent characteristic have been sorted from the k mixtures of micro-objects loaded into the microfluidic device at step 102. If steps 108 and 110 are repeated, at each repetition, the process 100 can test for a different subsequent characteristic at step 108. For example, at each performance of step 108, the process 100 can test for a subsequent characteristic that is not only different than the first characteristic but also different than any preceding subsequent characteristic tested during any previous pass through steps 108 and 110. At each performance of step 110, the process 100 can separate the micro-objects that test positive for the subsequent characteristic at step 108.
As noted, steps 108 and 110 can be repeated n times. After performing steps 108 and 110 n times, the process 100 has sorted from the k mixtures of micro-objects loaded into the microfluidic device at step 102 micro-objects that have all n+1 of the characteristics tested at steps 104 and 108. The number n can be an integer that is one or greater.
Variations of the process 100 are contemplated. For example, in some embodiments, the repetition of step 108 can sometimes test for a new characteristic not tested at step 104 or any previous performance of step 108 and other times test for the same characteristic tested at step 104 or a previous performance of step 108. As another example, at step 106 or any repetition of step 110, the process 100 can separate the micro-objects that tested negative from the micro-objects that tested positive. As yet another example, the process 100 can repeat step 104 multiple times before proceeding to step 106. In such an example, the process 100 can test for different characteristics at each repetition of step 104 and then separate the micro-objects that tested positive at each repetition of step 104 from micro-objects that tested negative to at least one repetition of step 104. Likewise, step 108 can be repeated multiple times before proceeding to step 110.
Examples of microfluidic devices 200 and 400 are now discussed with respect to
As shown, the housing 202 can comprise one or more flow regions 240 for holding a liquid medium 244.
The housing 202 can comprise one or more inlets 208 through which the medium 244 can be input into the flow region 240. An inlet 208 can be, for example, an input port, an opening, a valve, another channel, fluidic connectors, or the like. The housing 202 can also comprise one or more outlets 210 through which the medium 244 can be removed. An outlet 210 can be, for example, an output port, an opening, a valve, a channel, fluidic connectors, or the like. As another example, the outlet 210 can comprise a droplet outputting mechanism such as any of the outputting mechanisms disclosed in U.S. patent application Ser. No. 13/856,781 filed Apr. 4, 2013 (attorney docket no. BL1-US). All or part of the housing 202 can be gas permeable to allow gas (e.g., ambient air) to enter and exit the flow region 240.
The housing 202 can also comprise a microfluidic structure 204 disposed on a base (e.g., a substrate) 206. The microfluidic structure 204 can comprise a flexible material, such as rubber, plastic, an elastomer, silicone (e.g., patternable silicone), polydimethylsioxane (“PDMS”), or the like, which can be gas permeable. Alternatively, the microfluidic structure 204 can comprise other materials including rigid materials. The base 206 can comprise one or more substrates. Although illustrated as a single structure, the base 206 can comprise multiple interconnected structures such as multiple substrates. The micro-fluidic structure 104 can likewise comprise multiple structures, which can be interconnected. For example, the micro-fluidic structure 104 can additionally comprise a cover (not shown) made from material that is the same as or different than the other material in the structure.
The microfluidic structure 204 and the base 206 can define the flow region 240. Although one flow region 240 is shown in
As shown
The foregoing can be accomplished by orienting a pen 256 such that no opening into the pen 256 faces directly into the flow of medium 244 in a channel 252. For example, if the flow of medium is from the inlet 208 to the outlet 210 (and thus left to right) in the channel 252 in FIG. 2C, each of the pens 256 substantially impedes direct flow of medium 244 from the channel 252 into the pens 256 because the openings of each of the pens 256 do not face to the left in
There can be many such holding pens 256 in the flow region 240 disposed in any pattern, and the holding pens 256 can be any of many different sizes and shapes. Although shown as disposed against side walls of the microfluidic structure 204 in
The barriers 254 of the pens 256 can comprise any of the types of materials discussed above with respect to the microfluidic structure 204. The barriers 254 can comprise the same material as the microfluidic structure 204 or a different material. The barriers 254 can extend from the surface 242 of the base 206 across the entirety of the flow region 240 to an upper wall (opposite the surface 242) of the microfluidic structure 204 as shown in
The selector 222 can be configured to create selectively electrokinetic forces on micro-objects (not shown) in the medium 244. For example, the selector 222 can be configured to selectively activate (e.g., turn on) and deactivate (e.g., turn off) electrodes at the inner surface 242 of the flow region 240. The electrodes can create forces in the medium 244 that attract or repel micro-objects (not shown) in the medium 244, and the selector 222 can thus select and move one or more micro-objects in the medium 244. The electrodes can be, for example, dielectrophoresis (DEP) electrodes.
For example, the selector 222 can comprise one or more optical (e.g., laser) tweezers devices and/or one or more optoelectronic tweezers (OET) devices (e.g., as disclosed in U.S. Pat. No. 7,612,355 (which is incorporated in its entirety by reference herein) or U.S. patent application Ser. No. 14/051,004 (attorney docket no. BL9-US) (which is also incorporated in its entirety by reference herein). As yet another example, the selector 222 can include one or more devices (not shown) for moving a droplet of the medium 244 in which one or more of micro-objects are suspended. Such devices (not shown) can include electrowetting devices such as optoelectronic wetting (OEW) devices (e.g., as disclosed in U.S. Pat. No. 6,958,132). The selector 222 can thus be characterized as a DEP device in some embodiments.
In the example illustrated in
With the power source 312 activated, the foregoing creates an electric field gradient in the medium 244 between illuminated electrode regions 314a and adjacent dark electrode regions 314, which in turn creates local DEP forces that attract or repel nearby micro-objects (not shown) in the medium 244. DEP electrodes that attract or repel micro-objects in the medium 244 can thus be selectively activated and deactivated at many different such electrode regions 314 at the inner surface 242 of the flow region 240 by changing light patterns 322 projected form a light source 320 (e.g., a laser source or other type of light source) into the microfluidic device 200. Whether the DEP forces attract or repel nearby micro-objects can depend on such parameters as the frequency of the power source 312 and the dielectric properties of the medium 244 and/or micro-objects (not shown).
The square pattern 322′ of illuminated electrode regions 314a illustrated in
In some embodiments, the electrode activation substrate 308 can be a photoconductive material, and the inner surface 242 can be featureless. In such embodiments, the DEP electrodes 314 can be created anywhere and in any pattern on the inner surface 242 of the flow region 240 in accordance with the light pattern 322 (see
In other embodiments, the electrode activation substrate 308 can comprise a circuit substrate such as a semiconductor material comprising a plurality of doped layers, electrically insulating layers, and electrically conductive layers that form semiconductor integrated circuits such as is known in semiconductor fields. In such embodiments, electric circuit elements can form electrical connections between the electrode regions 314 at the inner surface 242 of the flow region 240 and the second electrode 310 that can be selectively activated and deactivated by the light pattern 322. When not activated, each electrical connection can have high impedance such that the relative impedance from a corresponding electrode region 214 to the second electrode 210 is greater than the relative impedance from the first electrode 204 through the medium 144 to the corresponding electrode region 214. When activated by light in the light pattern 222, however, each electrical connection can have low impedance such that the relative impedance from a corresponding electrode region 214 to the second electrode 210 is less than the relative impedance from the first electrode 204 through the medium 144 to the corresponding electrode region 214, which activates a DEP electrode at the corresponding electrode region 214 as discussed above. DEP electrodes that attract or repel micro-objects (not shown) in the medium 144 can thus be selectively activated and deactivated at many different electrode regions 214 at the inner surface 142 of the flow region 140 by the light pattern 222. Non-limiting examples of such configurations of the electrode activation substrate 308 include the phototransistor-based device 300 illustrated in
In some embodiments, the first electrode 304 can be part of a first wall 302 (or cover) of the housing 202, and the electrode activation substrate 308 and second electrode 310 can be part of a second wall 306 (or base) of the housing 202, generally as illustrated in
Configured as the DEP device 300 of
Although the barriers 254 that define the holding pens 256 are illustrated in
With reference again to
The detector 224 can alternatively or in addition comprise an imaging device for capturing digital images of the flow region 240 including micro-objects (not shown) in the medium 244. Examples of suitable imaging devices that the detector 224 can comprise include digital cameras or photosensors such as charge coupled devices and complementary metal-oxide-semiconductor imagers. Images can be captured with such devices and analyzed (e.g., by the control module 230 and/or a human operator).
The flow controller 226 can be configured to control a flow of the medium 244 in the flow region 240. For example, the flow controller 226 can control the direction and/or velocity of the flow. Non-limiting examples of the flow controller 226 include one or more pumps or fluid actuators. In some embodiments, the flow controller 226 can include additional elements such as one or more sensors (not shown) for sensing, for example, the velocity of the flow of the medium 244 in the flow region 240.
The control module 230 can be configured to receive signals from and control the selector 222, the detector 224, and/or the flow controller 226. As shown, the control module 230 can comprise a controller 232 and a memory 234. In some embodiments, the controller 232 can be a digital electronic controller (e.g., a microprocessor, microcontroller, computer, or the like) configured to operate in accordance with machine readable instructions (e.g., software, firmware, microcode, or the like) stored as non-transitory signals in the memory 234, which can be a digital electronic, optical, or magnetic memory device. Alternatively, the controller 232 can comprise hardwired digital circuitry and/or analog circuitry or a combination of a digital electronic controller operating in accordance with machine readable instructions and hardwired digital circuitry and/or analog circuitry. The controller 130 can be configured to perform all or any part of the processes 100, 400 disclosed herein.
In some embodiments, the pens 256 can be shielded from illumination (e.g., by the detector 224 and/or the selector 222) or can be only selectively illuminated for brief periods of time. Biological micro-objects 502 can thus be protected from further illumination or further illumination of the biological micro-objects 502 can be minimized after the biological micro-objects 502 are moved into the pens 256.
Each sequestration pen 436, 438, 440 can comprise an isolation structure 446 defining an isolation region 444 and a connection region 442 fluidically connecting the isolation region 444 to the channel 434. The connection region 442 can comprise a proximal opening 452 to the channel 434 and a distal opening 454 to the isolation region 444. The connection region 442 can be configured so that a maximum penetration depth of a flow of a fluidic medium (not shown) flowing at a maximum velocity (Vmax) in the channel 434 does not extend into the isolation region 444. A micro-object (not shown) or other material (not shown) disposed in an isolation region 444 of a pen 436, 438, 440 can thus be isolated from and not substantially affected by a flow of medium (not shown) in the channel 434. The channel 434 can thus be an example of a swept region, and the isolation regions of the sequestration pens 436, 438, 440 can be examples of unswept regions. Before turning to a more detailed discussion of the foregoing, a brief description of the microfluidic device 400 and examples of an associated control system 470 is provided.
The microfluidic device 400 can comprise an enclosure 402 enclosing the microfluidic circuit 432, which can contain one or more fluidic media. Although the device 400 can be physically structured in different ways, in the example shown in
The support structure 404 can be at the bottom and the cover 422 at the top of the device 400 as illustrated in
The microfluidic circuit structure 412 can define circuit elements of the microfluidic circuit 432 or circuits in the enclosure 402. In the example, illustrated in
The support structure 404 can comprise a substrate or a plurality of interconnected substrates. For example, the support structure 404 can comprise one or more interconnected semiconductor substrates, printed circuit boards, or the like. The frame 414 can partially or completely enclose the microfluidic circuit material 416. The frame 414 can be, for example, a relatively rigid structure substantially surrounding the microfluidic circuit material 416. For example the frame 414 can comprise a metal material.
The microfluidic circuit material 416 can be patterned with cavities or the like to define microfluidic circuit elements and interconnections of the microfluidic circuit 432. The microfluidic circuit material 416 can comprise a flexible material, such as rubber, plastic, elastomer, silicone (e.g., patternable silicone), PDMS, or the like, which can be gas permeable. Other examples of materials that can compose microfluidic circuit material 416 include molded glass, an etchable material such as silicon, photo-resist (e.g., SU8), or the like. In some embodiments, such materials—and thus the microfluidic circuit material 416—can be rigid and/or substantially impermeable to gas. Regardless, microfluidic circuit material 416 can be disposed on the support structure 404 and inside the frame 414.
The cover 422 can be an integral part of the frame 414 and/or the microfluidic circuit material 416. Alternatively, the cover 422 can be a structurally distinct element (as illustrated in
The control module 472 can comprise a digital controller 474 and a digital memory 476. The controller 474 can be, for example, a digital processor, computer, or the like, and the digital memory 476 can be a non-transitory digital memory for storing data and machine executable instructions (e.g., software, firmware, microcode, or the like) as non-transitory data or signals. The controller 474 can be configured to operate in accordance with such machine executable instructions stored in the memory 476. Alternatively or in addition, the controller 474 can comprise hardwired digital circuitry and/or analog circuitry. The control module 472 can thus be configured to perform all or part of any process (e.g., process 100 of
The control/monitoring equipment 480 can comprise any of a number of different types of devices for controlling or monitoring the microfluidic device 400 and processes performed with the microfluidic device 400. For example, the equipment 480 can include power sources (not shown) for providing power to the microfluidic device 400; fluidic media sources (not shown but can comprise a flow controller like 226 of
As noted, the control/monitoring equipment 480 can comprise motive modules for selecting and moving micro-objects (not shown) in the microfluidic circuit 432. A variety of motive mechanisms can be utilized. For example, dielectrophoresis (DEP) mechanisms (e.g., like the selector 222 of
An example of such a DEP configuration of the support structure 404 or the cover 422 is an optoelectronic tweezers (OET) configuration. Examples of suitable OET configurations of the support structure 404 or cover 422 and associated monitoring and control equipment are illustrated in the following U.S. patent documents each of which is incorporated herein by reference in its entirety: U.S. Pat. Nos. 7,612,355; 7,956,339; U.S. Patent Application Publication No. 2012/0325665; U.S. Patent Application Publication No. 2014/0124370; U.S. patent application Ser. No. 14/262,140 (pending); and U.S. patent application Ser. No. 14/262,200 (pending). Micro-objects (not shown) can thus be individually selected, captured, and moved within the microfluidic circuit 432 of the microfluidic device 400 utilizing DEP devices and techniques such as OET.
As noted, the channel 434 and pens 436, 438, 440 can be configured to contain one or more fluidic media (not shown). In the example shown in
As discussed above, each sequestration pen 436, 438, 440 can comprise a connection region 442 and an isolation region 444. The connection region 442 can comprise a proximal opening 452 to the channel 434 and a distal opening 454 to the isolation region 444. The channel 434 and each sequestration pen 436, 438, 440 can be configured so that the maximum penetration depth of a flow of medium (not shown) flowing in the channel 434 extends into the connection region 442 but not the isolation region 444.
Moreover, the flow 512 will not move miscellaneous particles (e.g., microparticles and/or nanoparticles) from the channel 434 into the isolation region 444 of a pen 436, nor will the flow 512 draw miscellaneous particles from the isolation region 444 into the channel 434. Having the length Lcon of the connection region 442 be greater than the maximum penetration depth Dp can thus prevent contamination of one pen 436 with miscellaneous particles from the channel 434 or another pen 438, 440.
Because the channel 434 and the connection regions 442 of the pens 436, 438, 440 can be affected by the flow 512 of medium 502 in the channel 434, the channel 434 and connection regions 442 can be deemed swept (or flow) regions of the microfluidic circuit 432. The isolation regions 444 of the pens 436, 438, 440, on the other hand, can be deemed unswept (or non-flow) regions. For example, a first medium 502 (e.g., components (not shown) in the first medium 502) in the channel 434 can mix with a second medium 504 (e.g., components (not shown) in the second medium 504) in the isolation region 444 substantially only by diffusion of the first medium 504 from the channel 434 through the connection region 442 and into the second medium 504 in the isolation region 444. Similarly, the second medium 504 (e.g., components (not shown) in the second medium 504) in the isolation region 444 can mix with the first medium 504 (e.g., components (not shown) in the first medium 502) in the channel 434 substantially only by diffusion of the second medium 502 from the isolation region 444 through the connection region 442 and into the first medium 502 in the channel 434. The first medium 502 can be the same medium or a different medium than the second medium 504. Moreover, the first medium 502 and the second medium 504 can start out being the same, then become different (e.g., through conditioning of the second medium by one or more biological micro-objects in the isolation region 444, or by changing the medium flowing through the channel 434).
The maximum penetration depth Dp of the secondary flow 514 caused by the flow 512 in the channel 434 can depend on a number of parameters. Examples of such parameters include: the shape of the channel 434 (e.g., the channel can direct medium into the connection region 442, divert medium away from the connection region 442, or simply flow past the connection region 442); a width Wch (or cross-sectional area) of the channel 434 at the proximal opening 452; a width Wcon (or cross-sectional area) of the connection region 442 at the proximal opening 452; the maximum velocity Vmax of the flow 512 in the channel 434; the viscosity of the first medium 502 and/or the second medium 504, or the like.
In some embodiments, the dimensions of the channel 434 and sequestration pens 436, 438, 440 can be oriented as follows with respect to the flow 512 in the channel 434: the channel width Wch (or cross-sectional area of the channel 434) can be substantially perpendicular to the flow 512, the width Wcon (or cross-sectional area) of the connection region 442 at the proximal opening 552 can be substantially parallel to the flow 512, and the length Lcon of the connection region can be substantially perpendicular to the flow 512. The foregoing are examples only, and the dimensions of the channel 434 and sequestration pens 436, 438, 440 can be in other orientations with respect to each other.
In some embodiments, the width Wch of the channel 434 at a proximal opening 452 can be within any of the following ranges: 50-1000 microns, 50-500 microns, 50-400 microns, 50-300 microns, 50-250 microns, 50-200 microns, 50-150 microns, 50-100 microns, 70-500 microns, 70-400 microns, 70-300 microns, 70-250 microns, 70-200 microns, 70-150 microns, 90-400 microns, 90-300 microns, 90-250 microns, 90-200 microns, 90-150 microns, 100-300 microns, 100-250 microns, 100-200 microns, 100-150 microns, and 100-120 microns. The foregoing are examples only, and the width Wch of the channel 434 can be in other ranges (e.g., a range defined by any of the endpoints listed above).
In some embodiments, the height Hch of the channel 134 at a proximal opening 152 can be within any of the following ranges: 20-100 microns, 20-90 microns, 20-80 microns, 20-70 microns, 20-60 microns, 20-50 microns, 30-100 microns, 30-90 microns, 30-80 microns, 30-70 microns, 30-60 microns, 30-50 microns, 40-100 microns, 40-90 microns, 40-80 microns, 40-70 microns, 40-60 microns, or 40-50 microns. The foregoing are examples only, and the height Hch of the channel 434 can be in other ranges (e.g., a range defined by any of the endpoints listed above).
In some embodiments, a cross-sectional area of the channel 434 at a proximal opening 452 can be within any of the following ranges: 500-50,000 square microns, 500-40,000 square microns, 500-30,000 square microns, 500-25,000 square microns, 500-20,000 square microns, 500-15,000 square microns, 500-10,000 square microns, 500-7,500 square microns, 500-5,000 square microns, 1,000-25,000 square microns, 1,000-20,000 square microns, 1,000-15,000 square microns, 1,000-10,000 square microns, 1,000-7,500 square microns, 1,000-5,000 square microns, 2,000-20,000 square microns, 2,000-15,000 square microns, 2,000-10,000 square microns, 2,000-7,500 square microns, 2,000-6,000 square microns, 3,000-20,000 square microns, 3,000-15,000 square microns, 3,000-10,000 square microns, 3,000-7,500 square microns, or 3,000 to 6,000 square microns. The foregoing are examples only, and the cross-sectional area of the channel 434 at a proximal opening 452 can be in other ranges (e.g., a range defined by any of the endpoints listed above).
In some embodiments, the length of the connection region Lcon can be in any of the following ranges: 1-200 microns, 5-150 microns, 10-100 microns, 15-80 microns, 20-60 microns, 20-500 microns, 40-400 microns, 60-300 microns, 80-200 microns, and 100-150 microns. The foregoing are examples only, and length Lcon of a connection region 442 can be in a different ranges than the foregoing examples (e.g., a range defined by any of the endpoints listed above).
In some embodiments, the width Wcon a connection region 442 at a proximal opening 452 can be in any of the following ranges: 20-500 microns, 20-400 microns, 20-300 microns, 20-200 microns, 20-150 microns, 20-100 microns, 20-80 microns, 20-60 microns, 30-400 microns, 30-300 microns, 30-200 microns, 30-150 microns, 30-100 microns, 30-80 microns, 30-60 microns, 40-300 microns, 40-200 microns, 40-150 microns, 40-100 microns, 40-80 microns, 40-60 microns, 50-250 microns, 50-200 microns, 50-150 microns, 50-100 microns, 50-80 microns, 60-200 microns, 60-150 microns, 60-100 microns, 60-80 microns, 70-150 microns, 70-100 microns, and 80-100 microns. The foregoing are examples only, and the width Wcon of a connection region 442 at a proximal opening 452 can be different than the foregoing examples (e.g., a range defined by any of the endpoints listed above).
In other embodiments, the width Wcon of a connection region 442 at a proximal opening 452 can be in any of the following ranges: 2-35 microns, 2-25 microns, 2-20 microns, 2-15 microns, 2-10 microns, 2-7 microns, 2-5 microns, 2-3 microns, 3-25 microns, 3-20 microns, 3-15 microns, 3-10 microns, 3-7 microns, 3-5 microns, 3-4 microns, 4-20 microns, 4-15 microns, 4-10 microns, 4-7 microns, 4-5 microns, 5-15 microns, 5-10 microns, 5-7 microns, 6-15 microns, 6-10 microns, 6-7 microns, 7-15 microns, 7-10 microns, 8-15 microns, and 8-10 microns. The foregoing are examples only, and the width Wcon of a connection region 442 at a proximal opening 452 can be different than the foregoing examples (e.g., a range defined by any of the endpoints listed above).
In some embodiments, a ratio of the length Lcon of a connection region 442 to a width Wcon of the connection region 442 at the proximal opening 452 of can be greater than or equal to any of the following ratios: 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, or more. The foregoing are examples only, and the ratio of the length Lcon of a connection region 442 to a width Wcon of the connection region 442 at the proximal opening 452 can be different than the foregoing examples.
As illustrated in
As also illustrated in
In some embodiments, the maximum velocity Vmax of a flow 512 in the channel 434 is the maximum velocity that the channel can maintain without causing a structural failure in the microfluidic device in which the channel is located. The maximum velocity that a channel can maintain depends on various factors, including the structural integrity of the microfluidic device and the cross-sectional area of the channel. For exemplary microfluidic devices of the present invention, the maximum flow velocity Vmax in a channel having a cross-sectional area of around 3,000 to 4,000 square microns is around 10 μL/sec. Alternatively, the maximum velocity Vmax of a flow 512 in channel 434 can be set so as to ensure that isolation regions 444 are isolated from the flow 512 in channel 434. In particular, based on the width Wcon of the proximal opening 452 of a connection region 442 of a sequestration pen 436, 438, 440, Vmax can be set so as to ensure that the depth of penetration Dp of a secondary flow 514 into the connection region is less than Lcon. For example, for a sequestration pen having a connection region with a proximal opening 452 having a width Wcon of about 30 to 40 microns, Vmax can be set around 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, or 1.5 μL/sec.
In some embodiments, the sum of the length Lcon of the connection region 442 and a corresponding length of the isolation region 444 of a sequestration pen 436, 438, 440 can be sufficiently short for relatively rapid diffusion of components of a second medium 504 in the isolation region 444 to a first medium 502 in the channel 434. For example, in some embodiments, the sum of (1) the length Lcon of the connection region 442 and (2) the distance between a biological micro-object located in isolation region 444 of a sequestration pen 436, 438, 440 and the distal opening 454 of the connection region can be in the following ranges: 40 microns to 300 microns, 50 microns to 550 microns, 60 microns to 500 microns, 70 microns to 180 microns, 80 microns to 160 microns, 90 microns to 140 microns, 100 microns to 120 microns, or any range including one of the foregoing end points. The rate of diffusion of a molecule (e.g., an analyte of interest, such as an antibody) is dependent on a number of factors, including temperature, viscosity of the medium, and the coefficient of diffusion D0 of the molecule. The D0 for an IgG antibody in aqueous solution at 20° C. is around 4.4×10−7 cm2/sec, while the viscosity of biological micro-object culture medium is around 9×10-4 m2/sec. Thus, for example, an antibody in biological micro-object culture medium at 20° C. can have a rate of diffusion of around 0.5 microns/sec. Accordingly, in some embodiments, a time period for diffusion from a biological micro-object located in isolation region 444 into the channel 434 can be about 10 minutes or less (e.g., 9, 8, 7, 6, 5 minutes, or less). The time period for diffusion can be manipulated by changing parameters that influence the rate of diffusion. For example, the temperature of the media can be increased (e.g., to a physiological temperature such as 37° C.) or decreased (e.g., to 15° C., 10° C., or 4° C.) thereby increasing or decreasing the rate of diffusion, respectively.
The configuration of sequestration pen 436 illustrated in
As another example, the sequestration pen 436 is shown extending generally perpendicularly from the channel 434 and thus forming generally 90° angles with the channel 434. The sequestration pen 436 can alternatively extend from the channel 434 at other angles such as, for example, any angle between 30° and 150°.
As yet another example, the connection region 442 and the isolation region 444 are illustrated in
As still another example, the connection region 442 and the isolation region 444 are illustrated in
The sequestration pen of
For example, the channel 434 and the sequestration pen of
The microfluidic device 700 of
Each sequestration pen 736 can comprise an isolation structure 746, an isolation region 744 within the isolation structure 746, and a connection region 742. From a proximal opening 772 at the channel 734 to a distal opening 774 at the isolation structure 736, the connection region 742 can fluidically connect the channel 734 to the isolation region 744. Generally in accordance with the discussion above of
As illustrated in
As illustrated in
With regard to the foregoing discussion about microfluidic devices having a channel and one or more sequestration pens, a fluidic medium (e.g., a first medium and/or a second medium) can be any fluid that is capable of maintaining a biological micro-object in a substantially assayable state. The assayable state will depend on the biological micro-object and the assay being performed. For example, if the biological micro-object is a biological micro-object that is being assayed for the secretion of a protein of interest, the biological micro-object would be substantially assayable provided that it is viable and capable of expressing and secreting proteins.
At step 102, the process 100 can load biological micro-objects into a micro-fluidic device.
As shown in
The biological micro-objects 802, 904 can be any biological micro-object 802, 904 to be assayed for production of a particular analyte or analytes of interest. Examples of biological micro-objects 802, 904 include biological micro-objects such as mammalian biological micro-objects, human biological micro-objects, immunological biological micro-objects (e.g., T biological micro-objects, B biological micro-objects, macrophages, etc.), B biological micro-object hydrodomas, stem biological micro-objects (e.g., bone marrow-derived stem biological micro-objects, adipose-derived stem biological micro-objects, etc.), transformed biological micro-objects lines (e.g., transformed CHO biological micro-objects, HeLa biological micro-objects, HEK biological micro-objects, etc.), insect biological micro-objects (e.g., Sf9, Sf21, HighFive, etc.), protozoan biological micro-objects (e.g., Leishmania tarentolae), yeast biological micro-objects (e.g., S. saccharomyces, P. pastoris, etc.), bacterial biological micro-objects (e.g., E. coli, B. subtilis, B. thuringiensis, etc.), any combination of the foregoing, or the like. Examples of biological micro-objects 904 also include embryos, such as mammalian embryos (e.g., human, primate, ursidae, canine, feline, bovine, ovis, capra, equus, porcine, etc.), or the like. Examples of the analyte of interest include a protein, a carbohydrate, a lipid, a nucleic acid, a metabolite, or the like. Other examples of the analyte of interest include a material that comprises an antibody such as an IgG (e.g., an IgG1, IgG2, IgG3, or IgG4 sub-class), an IgM, IgA, IgD, or IgE class antibody.
At step 104, the process 100 can perform a first test on the biological micro-objects loaded into the micro-fluidic device at step 102. Step 104 can include selecting ones of the biological micro-objects in accordance with the first test. Alternatively, step 104 can include selecting one of the biological micro-objects without performing the first test.
The first test can comprise any number of possible tests. For example, the first test, whether performed in the microfluidic device 200 or 400, can test for a first characteristic of the biological micro-objects 802 or biological micro-objects 904. The first test performed at step 104 can be any test that tests for any desired characteristic. For example, the desired characteristic can relate to the size, shape, and/or morphology of the biological micro-objects 802 or biological micro-objects 904. The first test can comprise capturing images of the biological micro-objects 802 or biological micro-objects 904 and analyzing the images to determine which of the biological micro-objects 802 or biological micro-objects 904 have the desired characteristic. As another example, the first test performed at step 104 can determine which of the biological micro-objects 802 or biological micro-objects 904 exhibit a particular detectable condition that indicates the first characteristic. For example, the first characteristic could be expression of one or more cell-surface markers and the first test performed at step 104 could detect the presence or absence of such cell-surface markers on the biological micro-objects 802, 904. By testing for an appropriate cell-surface marker or combination of cell-surface markers, particular cell types can be identified and selected at step 104. Examples of such particular cell types can include healthy cells, cancer cells, infected cells (e.g., infected with a virus or a parasite), immunological cells (e.g., B cells, T cells, macrophages), stem cells, and the like.
In the example shown in
Examples of the first characteristic tested at step 104 can include, without limitation, a biological state (e.g., cell type) or a particular biological activity of the biological micro-objects 802. For example, the first characteristic can be an observable physical characteristic, such as size, shape, color, texture, surface morphology, identifiable sub-components, or other characteristic marks. Alternatively, the first characteristic can be an assayable characteristic, such as permeability, conductivity, capacitance, response to changes in the environment, or producing (e.g., expressing, secreting or the like) a particular biological material of interest. The particular biological material of interest can be a cell-surface marker (e.g., a membrane associated protein, glycoprotein, or the like). Another example of a particular biological material of interest is a therapeutic protein, such as an antibody (e.g., IgG-type antibody) that specifically binds to an antigen of interest. Thus, selected biological micro-objects 1002 can be one or more of the biological micro-objects 802 that test positive for producing (e.g., expressing) a particular biological material such as a cell-surface marker, and unselected biological micro-objects 1004 can be biological micro-objects 802 that do not test positive for the foregoing. Suitable assay materials with which the biological micro-objects 802 can be pretreated include a reagent that both binds to the particular biological material of interest and includes labels that radiate the energy 1206.
As shown in
Although the example shown in
In some embodiments, the control module 472 can perform the first test at step 104 by causing the control/monitoring equipment 480 to capture images of the biological micro-objects 904 in the sample material 902. The control module 472, which can be configured with known image analysis algorithms, can analyze the images and identify ones of the biological micro-objects 904 that have the desired characteristics. Alternatively, a human user can analyze the captured images.
For assaying characteristics of biological micro-objects, a human user and/or the control module 472 can control the assaying. For example, biological micro-objects such as biological micro-objects can be assayed for permeability, conductivity, or biological micro-object-type specific markers (e.g., using antibodies specific to biological micro-object-surface proteins).
At step 106, the process 100 can separate the selected biological micro-objects or biological micro-objects selected as part of step 104. However, if biological micro-objects are selected without performing a first step at step 104, step 106 can be skipped or can consist of simply flushing unselected biological micro-objects out of channel 252 (and, optionally, out of flow region 240 as well).
As noted above with respect to
The light traps 1102 can be part of a changing pattern 322 of light projected onto an inner surface 242 of the flow region 240 of the microfluidic device 200 as discussed above with respect to
As shown in
The selected biological micro-objects 1202, 1204, 1206 can be moved into the isolation regions 444 of the sequestration pens 436, 438, 440 of the microfluidic device 400 in any of a number of possible ways. For example, as discussed above, the enclosure 402 of the microfluidic device can include DEP configurations, which can be utilized to capture and move particular ones of the biological micro-objects 904 in the sample material 902.
For example, as illustrated in
Although one selected biological micro-object 1202, 1204, 1206 per pen 436, 438, 444 is shown in the example in of
In some embodiments, at least part of the sample material 902 can be loaded at step 104 into the isolation regions 444 of the pens 436, 438, 440. Also as part of step 104, the micro-objects 1202, 1204, 1206 can be selected in the isolation regions 144. In such embodiments, the sample material 902 including the unselected micro-objects 904 can be removed from the isolation regions 444 at step 106, leaving only the selected micro-objects 1202, 1204, 1206 in the isolation regions 444.
As illustrated in
In some embodiments, the control module 472 can cause the control/monitoring equipment 480 to clear the channel 434. For example, the control module 472 can cause the control/monitoring equipment 480 to flow a flushing medium through a port 424 into the channel 434 and out of another port 424. The control module 472 can keep the velocity of the flow 1602 below the maximum flow velocity Vmax. For example, for a channel 434 having a cross-sectional area of about 3,000 to 6,000 square microns (or about 2,500 to 4,000 square microns), the control module 472 can keep the velocity of the flow 1602 below a Vmax of 5.0 μL/sec (e.g., 4.0, 3.0, or 2.0 μL/sec).
After steps 102-106, the process 100 has sorted a mixture of biological micro-objects (e.g., 802, 904) in a microfluidic device (e.g., 200, 400) into selected biological micro-objects (e.g., 1004, 1202, 1204, 1206) and unselected biological micro-objects (e.g., 1004, 904). The process 100 has also placed the selected biological micro-objects in holding pens (e.g., 256, 436, 438, 440) in the microfluidic device and flushed the unselected biological micro-objects away. As discussed above, steps 102-106 can be repeated and thus performed k times, where k is one (in which case steps 102-106 are performed once but not repeated) or greater. The result can be numerous selected biological micro-objects in holding pens in the microfluidic device.
It is also noted that step 104 can be performed 1 times testing for up to 1 different characteristics before performing step 106, where 1 is a positive integer one or greater. For example, step 104 can test for a first characteristic of the biological micro-objects, such as size, shape, morphology, texture, visible markers, or the like, after which step 104 can be repeated to test for a subsequent characteristic, such as an assayable characteristic. Thus, the selected biological micro-objects can comprise biological micro-objects from the group(s) of biological micro-objects loaded at step 102 that test positive for as many as l different characteristics.
As noted, moving the selected biological micro-objects from the channel (e.g., 252, 434) into the pens and flushing the unselected biological micro-objects from the channel is but one example of how step 106 can be performed. Other examples include, moving the unselected biological micro-objects from the channel into the pens and flushing the selected biological micro-objects from the channel. For example, the selected biological micro-objects can be flushed from the channel and collected elsewhere in the microfluidic device or delivered to another device (not shown), where the selected biological micro-objects can be further processed. The unselected biological micro-objects can later be removed from the holding pens and discarded.
At step 108, the process 100 can perform a test on the selected biological micro-objects or biological micro-objects. This test can be a subsequent test (e.g., a second test) if a first test was performed as part of step 104. (Hereinafter, the test performed at step 108 is referred to as a “subsequent test” to distinguish from the “first test” referred to above in discussing step 104.) As noted above, the subsequent test performed at step 108 can test for the same characteristic (i.e., the first characteristic) as the first test of step 104 or a different characteristic. As also noted above, if the subsequent test performed at step 108 is for the first characteristic (and thus the same characteristic tested at step 104), the subsequent test can nevertheless be different than the first test. For example, the subsequent test can be more sensitive than the first test to detection of the first characteristic.
As illustrated in
The detectable condition can be radiation of energy having one or more criteria such as threshold intensity, frequency in a particular frequency band, or the like. A color of the biological micro-objects 1002 is an example of radiating electromagnetic radiation in a particular frequency band. In the example shown in
An example of the subsequent characteristic tested at step 410 can be viability of the biological micro-objects 1002. For example, the subsequent characteristic can be whether the biological micro-objects 1002 are alive or dead, and the assay material can be a viability dye such as 7-aminoactinomycin D. Such a dye can cause biological micro-objects 1002 that are alive to turn a particular color and/or dead biological micro-objects to turn a different color. The detector 224 (see
In the example illustrated in
As shown in
The assay material 1910 can be flowed into the channel 434 sufficiently fast so that the assay material 1910 is in place adjacent the proximal openings 452 of the pens 436, 438, 440 before analyte components 1904 produced in any of the pens 436, 438, 440 can diffuse into the channel 434. This can avoid a problem of analyte components 1904 from one pen 436, 438, 440 contaminating the channel 434 and/or other pens between the time when selected biological micro-objects 1202, 1204, 1206 are disposed into the pens 436, 438, 440 and completion of the loading of the assay material 1910 into the channel 434.
The velocity at which the assay material 1910 is loaded into the channel 434 can thus be at least a minimum flow velocity Vmin that fully loads the assay material 1910 into place adjacent the proximal openings 452 over a time period Tload that is less than a minimum time period Tdiff for a substantial amount of analyte components 1904 to diffuse from an isolation region 444 of a pen 436, 438, 440 into the channel 434. A “substantial amount” as used in this context means a detectable amount of analyte components that is sufficient to interfere with accurate detection of which sequestration pen the analyte components came from). The minimum flow velocity Vmin can be a function of a variety of different parameters. Examples of such parameters include the length of the channel 434, the length Lcon of a connection region 442 of a pen 436, 438, 440, a diffusion rate of analyte components 1904, medium viscosity, ambient temperature, or the like. Examples of the minimum flow velocity Vmin include at least about 0.04 μL/sec (e.g., at least about 0.10, 0.11, 0.12, 0.13, 0.14, μL/sec, or higher).
The minimum flow velocity Vmin for loading assay material 1910 into the channel 434 can be less than the maximum flow velocity Vmax corresponding to a penetration depth Dp that is less than the length Lcon of a connection region 442 of a pen 436, 438, 440 as discussed above. For example, a ratio of Vmax/Vmin can be in any of the following ranges: about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 40, 50, 100, or more.
The incubation period provided after loading the assay material 1910 can be sufficient for the biological micro-objects 1202, 1204, 1206 to produce the analyte of interest 1902 and for analyte components 1904 to diffuse from the isolation regions 444 of the pens 436, 438, 440 to corresponding connection regions 442 or proximal openings 452. For example, the incubation period can provide analyte components 1904 sufficient time to diffuse into the channel 434.
The incubation period can comprise merely passively allowing the biological micro-objects 1202, 1204, 1206 to naturally produce the analyte of interest 1902 in the sequestration pens 436, 438, 440. Alternatively, the incubation period can comprise actively stimulating the biological micro-objects 1202, 1204, 1206 to produce the analyte of interest 1902 by, for example, providing nutrients, growth factors, and/or inductive factors to the biological micro-objects 1202, 1204, 1206; controlling the temperature, chemical composition, pH, or the like of the medium in the isolation regions 444 of the sequestration pens 436, 438, 440; directing stimulating energy such as light into the isolation regions 444; or the like.
The term “incubation” and “incubate,” as used herein, cover the foregoing range from merely passively allowing the biological micro-objects 1202, 1204, 1206 to naturally produce analyte 1902 in the sequestration pens 436, 438, 440 to actively stimulating production of the analyte. Stimulating the production of analyte 1902 can also include stimulating the growth of a biological micro-object 1202, 1204, 1206. Thus, for example, biological micro-objects 1202, 1204, 1206 can be stimulated to grow prior to and/or while they are being stimulated to produce an analyte of interest 1902. If the biological micro-objects 1202, 1204, 1206 have been loaded into sequestration pens 436, 438, 440 as single biological micro-objects, growth stimulation can result in the production of clonal biological micro-object populations which express and/or secrete (or can be stimulated to express and/or secrete) an analyte of interest.
In some embodiments, the control module 472 can cause the control/monitoring equipment 480 to perform one or more actions during the incubation period 150. For example, the control module 472 can cause the control/monitoring equipment 480 to provide growth medium and/or inductive medium either periodically or as a continuous flow. Alternatively, control module 472 can cause the control/monitoring equipment 480 to incubate the biological micro-objects for a period of time sufficient for the analyte of interest to diffuse into the channel 434. For example, in the case of a protein analyte such as an antibody, the control module 472 can provide time for diffusion equal to around 2 seconds for every 1 micron that the biological micro-object is separated from the channel 434. For proteins and other analytes significantly smaller than an antibody, the time needed for diffusion may be smaller, such as 1.5 seconds for every 1 micron, or less (e.g., 1.25 s/μm, 1.0 s/μm, 0.75 s/μm, 0.5 s/μm, or less). Conversely, for proteins or other analytes significantly larger than an antibody, the time allotted for diffusion may be larger, such as 2.0 seconds for every micron, or more (e.g., 2.25 s/μm, 2.5 s/μm, 2.75 s/μm, 3.0 s/μm, or more).
It is noted that the incubation period can continue during performance of subsequent steps of the process 100. Also, the incubation period can begin prior to completion of step 106 (e.g., during any of steps 102-106).
The assay material 1910 can be configured both to interact with analyte components 1904 of an analyte of interest 902 and to produce a detectable reaction from the interaction. As illustrated in
The localized reactions 2002 can be detectable reactions. For example, the reactions 2002 can be localized luminescence (e.g., fluorescence). Moreover, the localized reactions 2002 can be sufficiently localized and separated to be separately detectable by a human observer, a camera (not shown) in the control/monitoring equipment 480 of
Proximal openings 452 of contiguous sequestration pens 436, 438, 440 can be spaced apart by at least a distance Ds (see
As noted, the assay material 1910, including components such as capture micro-objects (e.g., biological micro-objects, beads, or the like), can enter and thus be disposed at least in part in the connection regions 442 of the sequestration pens 436, 438, 440. In such a case, the reactions 2002, 2004 can occur entirely, substantially entirely, or partially in the connection regions 442 as opposed to substantially entirely in the channel 434. Moreover, capture micro-objects (e.g., biological micro-objects, beads, or the like) in the assay material 1910 can be disposed into isolation regions 444. For example, DEP forces or the like can be used to select and move capture micro-objects into isolation regions 444. For capture micro-objects that are disposed in the isolation region of a sequestration pen, the capture micro-objects can be disposed proximal to the biological micro-object(s) and/or in a portion (e.g., a sub-compartment) of the isolation region that is distinct from the portion occupied by the biological micro-object(s).
The assay material 1910 can be any material that specifically interacts, either directly or indirectly, with the analyte of interest 1902 to produce a detectable reaction (e.g., 2002).
Binding of analyte components 1904 to labeled capture micro-objects 2112 is greatest when the labeled capture micro-objects 2112 are immediately adjacent or internal to a proximal opening 452. This is because the concentration of analyte components 1904 is highest in isolation region 444 and connection region 442, thereby favoring binding of the analyte components 1904 to the labeled capture micro-objects 2112 and facilitating their aggregation in those regions. As analyte components 1904 diffuse out into the channel 234 and away from the proximal opening 252, their concentration goes down. As a result, fewer analyte components 1904 bind to labeled capture micro-objects 2112 that are located away from the proximal opening 252. The reduction in binding of analyte components 1904 to labeled capture micro-objects 2112 results, in turn, in reduced aggregation of the labeled capture micro-objects 2112 located away from the proximal opening 452. Labeled capture micro-objects 2112 that are not immediately adjacent (or internal) to a proximal opening 452 of a pen 436, 438, 440 thus do not produce a detectable localized reaction 2002 (or produce a localized reaction 2002 that is detectably lower in magnitude than the localized reaction 2002 that takes place immediately adjacent or internal to the proximal opening 452).
For analyte components that do not have two binding sites for a binding substance on the labeled capture micro-objects 2112, the labeled capture micro-objects could include two different binding substances (as discussed below and shown in
Examples of labeled capture micro-objects 2112 include both inanimate and biological micro-objects. Examples of inanimate micro-objects include micro-structures such as microbeads (e.g., polystyrene microbeads), microrods, magnetic beads, quantum dots, and the like. The micro-structures can be large (e.g., 10-15 microns in diameter, or larger) or small (e.g., less than 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 microns in diameter, or smaller). Examples of biological micro-objects include biological micro-objects (e.g., reporter biological micro-objects), liposomes (e.g., synthetic or derived from membrane preparations), microbeads coated with liposomes, lipid nanorafts (see, e.g., Ritchie et al. (2009) “Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs,” Methods Enzymol., 464:211-231), and the like.
As analyte components 1904 produced by the biological micro-object 1202 in the isolation region 444 of sequestration pen 436 diffuse towards the proximal opening 452, the analyte components 1904 can bind to a capture micro-object 2212 and a label 2222 immediately adjacent (or internal) to opening 452, thereby resulting in accumulation of label 2112 on the surface of the capture micro-object 2212. Binding of analyte components 1904 to labeled capture micro-objects 2212 is greatest when the capture micro-objects 2212 are immediately adjacent (or internal) to a proximal opening 452. Similar to the discussion above, this is because the relatively high concentration of analyte components 1904 in isolation region 444 and connection region 442 facilitate the binding of analyte components 1904 to the capture micro-objects 2212 and concomitant association of label 2222 at the surface of the capture micro-objects 2212. As analyte components 1904 diffuse out into the channel 434 and away from the proximal opening 452, the concentration goes down and fewer analyte components 1904 bind to capture micro-objects 2212 that are located away from the proximal opening 452. The reduction in binding of analyte components 1904 to capture micro-objects 2212 results in reduced accumulation of label 2222 at the surface of the capture micro-objects 2112 located away from the proximal opening 452. Accordingly, capture micro-objects 2212 that are not immediately adjacent (or internal) to a proximal opening 452 of a pen 436, 438, 440 do not become detectably labeled or, to the extent that they do become labeled, the labeling is detectably lower in magnitude than the labeling that takes place immediately adjacent or internal to the proximal opening 452.
Examples of capture micro-objects 2212 include all of the examples identified above for labeled capture micro-object 2112. Examples of the first affinity agent 2312 include a receptor that specifically recognizes the analyte components 1904 or a ligand that is specifically recognized by the analyte components 1904. For example, in the case of an antibody analyte, the first affinity agent 2312 can be an antigen of interest.
Examples of labels 2222 include labeling agents comprising luminescent labels (e.g., fluorescent labels) and labeling agents comprising enzymes capable of cleaving a signal molecule that fluoresces upon cleavage.
Examples of the assay material 1910 include assay materials comprising composite capture micro-objects that include multiple affinity agents.
Examples of the first affinity agent 2402 include those discussed above. Examples of the second affinity agent 2404 include a receptor that specifically recognizes the second region 2304 of the analyte components 1904 or a ligand that is specifically recognized by the second region 2304 of the analyte components 1904. For example, in the case of an antibody analyte, the second affinity agent 2404 can bind to the constant region of an antibody. Examples of the foregoing include an Fc molecule, an antibody (e.g., an anti-IgG antibody), Protein A, Protein G, and the like.
Another example of the assay material 1910 is one that comprises multiple capture micro-objects. For example, the assay material 1910 can comprise first capture micro-objects (not shown) comprising the first affinity agent 2402 and second capture micro-objects (not shown) comprising the second affinity agent 2404. The first capture micro-objects can be different than the second capture micro-objects. For example, the first capture micro-objects can have a size, color, shape, or other characteristic that distinguishes the first capture micro-objects from the second capture micro-objects. Alternatively, the first capture micro-objects and the second capture micro-objects can be substantially the same type of capture micro-objects, with the exception of the type of affinity agent each comprises.
Another example of the assay material 1910 is one that comprises multiple types of capture micro-objects, each of which is designed to bind to a different analyte of interest. For example, the assay material 1910 can comprise first capture micro-objects (not shown) comprising a first affinity agent and second capture micro-objects (not shown) comprising a second affinity agent, wherein the first and second affinity agents do not bind to the same analyte of interest. The first capture micro-objects can have a size, color, shape, label, or other characteristic that distinguishes the first capture micro-objects from the second capture micro-objects. In this manner, multiple analytes of interest can be screened for at the same time.
Regardless of the specific content of the assay material 1910, in some embodiments, the control module 472 can cause the control/monitoring equipment 480 to load the assay material 1910 into the channel 434. The control module 472 can keep the flow of the assay material 1910 in the channel 434 between the minimum flow velocity Vmin and the maximum flow velocity Vmax discussed above. Once the assay material 1910 is in place adjacent the proximal openings 452 of the pens 436, 438, 440, the control module 472 can substantially stop the flow of the assay material 1910 in the channel 434.
Performed in the microfluidic device 400, step 108 can include detecting localized reactions 2002 immediately adjacent one or more of the proximal openings 452 of the sequestration pens 436, 438, 440 that indicate reaction of analyte components 1904 with the assay material 1910 loaded into the channel 434. If localized reactions 2002 are detected immediately adjacent any of the proximal openings 452 of the sequestration pens 436, 438, 440, it can be determined whether any of those detected localized reactions 2002 indicate positive performance of one or more of the biological micro-objects 1202, 1204, 1206 in the sequestration pens 436, 438, 440. In some embodiments, a human user can observe the channel 434 or connections regions 442 of the pens 436, 438, 440 to monitor for and determine whether localized reactions 2002 indicate positive performance of biological micro-object 1202, 1204, 1206. In other embodiments, the control module 472 can be configured to do so. The process 2500 of
At step 2502, the control module 472 performing the process 2500 can capture at least one image of the channel 434 or connection regions 442 of the sequestration pens 436, 438, 440 with a camera or other image capture device (not shown but can be an element of the control/monitoring equipment 480 of
At step 2504, the control module 472 can identify in the final image any indications of localized reactions 2002. As discussed above, examples of the localized reactions 2002 include luminescence (e.g., fluorescence), and the control module 472 can thus analyze the final image for luminescence immediately adjacent any of the proximal openings 452 of the sequestration pens 436, 438, 440. The control module 472 can be programmed to utilize any image processing technique to identify localized reactions 2002 in the final image. In the example, illustrated in
At step 2506, the control module 472 can correlate each localized reaction 2002 detected at step 2504 to a corresponding sequestration pen 436, 438, 440. For example, the control module 472 can do so by correlating each localized reaction 2002 detected at step 2504 to the sequestration pen 436, 438, 440 with the nearest proximal opening 452 to the reaction 1002. In the example of
The control module 472 can perform steps 2508 and 2510 of
At step 2508, the control module 472 can determine whether the detected reaction 1002 correlated to the current sequestration pen 436 indicates a positive result for the biological micro-object(s) 1202 in the current pen 436. For example, the control module 472 can extract data regarding the detected reaction 1002 from the final image obtained at step 2502, and determine whether the extracted data indicates a positive result. Any number of different criteria can be used. For example, the detected reaction 2002 can be luminescence, and the criteria for determining a positive result can include intensity of the luminescence exceeding a threshold, brightness of the luminescence exceeding a threshold, color of the luminescence falling within a predetermined color range, or the like. If at step 2508, the control module 472 determines that the detected reaction is positive, the control module 472 can proceed to step 2510, where the control module 472 can identify the current sequestration pen 436 as containing a positive biological micro-object 1202. If the determination at step 2508 is negative, the control module 472 can repeat step 2508 for the next sequestration pen 438 for which a detected reaction was correlated at step 2506.
In the example illustrated in
Returning to
As shown in
The light traps 2602 can be generated and manipulated as discussed above. For example, as illustrated, each negative biological micro-object 2602 can be individually trapped and moved from a holding pen 256 into the channel 252. Alternatively, more than one negative biological micro-object 2602 can be trapped by a single trap 2602. For example, there can be more than one biological micro-object 2602 in a single pen 256. Regardless, two or more of the negative biological micro-objects 2602 can be selected in the pens 256 and moved in parallel into the channel 252.
The detector 224 can capture images of all or part of the flow region 240 including images of the biological micro-objects 1002 in the pens 256, and those images can facilitate identifying, trapping, and moving individual negative biological micro-objects 2602 out of specific pens 256 and into the channel 252. The detector 224 and/or the selector 222 (e.g., configured as the DEP device of
As shown in
Alternatively, the biological micro-objects 1002 that tested positive at step 108 can be moved from the pens 256 into the channel 252 and flushed by the flow 804 from the channel 252 at step 110. In such an example, the biological micro-objects 1002 that tested positive at both steps 104 and 108 can be collected elsewhere in the microfluidic device 200 for storage, further processing, delivery to another device (not shown), or the like. The biological micro-objects 1802 that tested negative at step 108 can later be removed from the holding pens 256 and discarded.
As shown in
After steps 108 and 110, the process 100 has further sorted the micro-objects (e.g., 1002, 1202, 1204, 1206) selected at step 104 in accordance with a test performed at step 108. Moreover, the micro-objects selected at step 104 that also tested positive to the subsequent test at step 108 can remain in the holding pens (e.g., 256, 436, 438, 440), while negative micro-objects can be removed.
As discussed above, steps 108 and 110 can be repeated and thus performed n times, where n is an integer one (in which case steps 108 and 110 are performed once but not repeated) or greater. The subsequent test performed at each repetition of step 108 can be a different test. Alternatively, the subsequent test performed at a repetition of step 108 can be the same test as was previously performed at step 104 or a prior performance of step 108. The biological micro-objects (e.g., biological micro-objects) loaded at step 102 can thus be subjected to a sequence of n+1 tests. In some embodiments, each of the n+1 tests can be a different test, and in some embodiments, each of the n+1 tests can test for a different characteristic. The process 100 can thus sort from initial mixtures of biological micro-objects a group that test positive to n+1 tests each of which can be different, and in some embodiments, the process 100 can sort from initial mixtures of biological micro-objects a group that test positive for n+1 different characteristics.
Alternatively, the process 100 can select biological micro-objects at step 104 and then rank the selected biological micro-objects according to the number of tests at step 108 (either performed simultaneously or by repeating step 108) in which the biological micro-objects test positive. Testing for multiple characteristics in this manner is desirable for numerous applications, including antibody characterization. For example, the multiple tests can help with any of the following: identifying conformation specific antibodies (e.g., the different tests can assess the ability of an antibody analyte to bind different conformation of a particular antigen); epitope mapping of an antibody analyte (e.g., using genetically or chemically altered antigen); assessing species cross-reactivity of an antibody analyte (e.g., different tests can assess the ability of antibody analyte to bind to homologous antigens originating from human, mouse, rat, and/or other animals (e.g., experimental animals); and IgG isotyping of an antibody analyte. The generation of chemically modified antigen for epitope mapping of antibodies has been described, for example, in Dhungana et al. (2009), Methods Mol. Biol. 524:119-34.
The entire process 100 can be repeated one or more times. Thus, after performing steps108 and 110 n times, steps 102-106 can again be performed k times followed by n more performances of steps 108 and 110. The number k need not be the same number for each repetition of the process 100. Similarly, the number n need not be the same number for each repetition of the process 100. For example, the final repetition of steps 108 and 110 for a particular repetition of the process 100, the flow 804 shown in
The process 100 can similarly be repeated multiple times on the microfluidic device 400. For example, the process 100 can be repeated to retest or reanalyze the positive biological micro-objects kept in their sequestration pens 436, 438, 440 at step 110; to retest or reanalyze positive biological micro-objects at reduced density (e.g., one biological micro-object per sequestration pen, assuming that the initial test was performed with multiple biological micro-objects per sequestration pen); to test or analyze new biological micro-objects loaded into the microfluidic device 400 at the next repetition of step 108; to test or analyze the positive biological micro-objects kept in their sequestration pens 436, 438, 440 at step 110 with respect to a different analyte material (e.g., by repeating step 108 with assay material 1910 designed to detect a second or additional analyte of interest); or the like.
Although specific embodiments and applications of the invention have been described in this specification, these embodiments and applications are exemplary only, and many variations are possible. For example, the process 100 of
A screen was performed to identify mouse splenocytes that secrete IgG-type antibodies that bind to human CD45. The experimental design included the following steps:
Reagents used for the experiment included those shown in Table 1.
CD45 antigen coated microbeads were generated in the following manner:
50 μg carrier free CD45 was resuspended in 500 μL PBS (pH 7.2).
A slide-a-lyzer mini cup was rinsed with 500 μL PBS, then added to a microfuge tube.
50 μL of the 0.1 μg/μL CD45 solution was added to the rinsed slide-a-lyzer mini cup.
170 μL PBS was added to 2 mg of NHS-PEG4-Biotin, after which 4.1 μL of NHS-PEG4-Biotin was added to the slide-a-lyzer mini cup containing the CD45 antigen.
The NGS-PEG4-Biotin was incubated with the CD45 antigen for 1 hour at room temperature.
Following the incubation, the slide-a-lyser mini cup was removed from the microfuge tube, placed into 1.3 mls PBS (pH 7.2) in a second microfuge tube, and incubated at 4° C. with rocking, for a first 1 hour period. The slide-a-lyser mini cup was subsequently transferred to a third microfuge tube containing 1.3 mls of fresh PBS (pH 7.2), and incubated at 4° C. with rocking, for a second 1 hour period. This last step was repeated three more times, for a total of five 1 hour incubations.
100 μL of biotinylated CD45 solution (˜50 ng/μL) was pipetted into labeled tubes.
500 μL Spherotech streptavidin coated beads were pipetted into a microfuge tube, washed 3 times (1000 μL/wash) in PBS (pH 7.4), then centrifuges for 5 min at 3000 RCF.
The beads were resuspended in 500 μl PBS (pH 7.4), resulting in a bead concentration of 5 mg/ml.
50 μL biotinylated protein was mixed with the resuspended Spherotech streptavidin coated beads. The mixture was incubated at 4° C., with rocking, for 2 hours, then centrifuged 4° for 5 min at 3000 RCF. The supernatant was discarded and the CD45 coated beads were washed 3 times in 1 mL PBS (pH 7.4). The beads were then centrifuges at 4° C. for another 5 min at 3000 RCF. Finally, the CD45 beads were resuspended in 500 μL PBS pH 7.4 and stored at 4° C.
The spleen from a mouse immunized with CD45 was harvested and placed into DMEM media+10% FBS. Scissors were used to mince the spleen.
Minced spleen was placed into a 40 μm cell strainer. Single cells were washed through the cell strainer with a 10 ml pipette. A glass rod was used to break up the spleen further and force single cells through the cell strainer, after which single cells were again washed through the cell strainer with a 10 ml pipette.
Red blood cells were lysed with a commercial kit.
Cells were spun down at 200×G and raw splenocytes were resuspended in DMEM media+10% FBS with 10 ml pipette at a concentration of 2e8 cells/ml.
Loading Cells into Microfluidic Device
Splenocytes were imported into the microfluidic chip and loaded into pens containing 20-30 cells per pen. 100 μL of media was flowed through the device at 1 μL/s to remove unwanted cells. Temperature was set to 36° C., and culture media was perfused for 30 minutes at 0.1 μL/sec.
Cell media containing 1:2500 goat anti-mouse F(ab′)2-Alexa 568 was prepared. 100 μL of CD45 beads were re-suspend in 22 μL of the cell media containing the 1:2500 dilution of goat anti-mouse F(ab′)2-Alexa 568.
The resuspended CD45 beads were next flowed into the main channel of the microfluidic chip at a rate of 1 μL/sec until they were located adjacent to, but just outside the pens containing splenocytes. Fluid flow was then stopped.
The microfluidic chip was then imaged in bright field to determine the location of the beads.
Next, a Texas Red Filter was used to capture images of the cells and beads. Images were taken every 5 minutes for 1 hr, with each exposure lasting 1000 ms and a gain of 5.
Positive signal was observed developing on the beads, reflecting the diffusion of IgG-isotype antibodies diffusing out of certain pens and into the main channel, where they were able to bind the CD45-coated beads. Binding of anti-CD45 antibody to the beads allowed for the secondary goat anti-mouse IgG-568 to associate with the beads and produce a detectable signal. See
Using the methods of the invention, each group of splenocytes associated with positive signal could be separated and moved into new pens as a single cell and reassayed. In this manner, single cells expressing anti-CD45 IgG antibodies could be detected.
In addition to any previously indicated modification, numerous other variations and alternative arrangements may be devised by those skilled in the art without departing from the spirit and scope of this description. Thus, while the information has been described above with particularity and detail in connection with what is presently deemed to be the most practical and preferred aspects, it will be apparent to those of ordinary skill in the art that numerous modifications, including, but not limited to, form, function, manner of operation, and use may be made without departing from the principles and concepts set forth herein. As used herein, the examples and embodiments, in all respects, are meant to be illustrative only and should not be construed to be limiting in any manner. It should also be noted, that while the term step is used herein, that term may be used to simply draw attention to different portions of the described methods and is not meant to delineate a starting point or a stopping point for any portion of the methods, or to be limiting in any other way.
This application is a non-provisional of (and thus claims the benefit of and/or priority to) U.S. converted provisional patent application Ser. No. 14/060,321. (The foregoing application Ser. No. 14/060,321 was filed on Oct. 22, 2013 as a regular patent application but converted to a provisional patent application in response to a Petition filed Oct. 7, 2014, which was granted Oct. 9, 2014.) This application is also a non-provisional of (and thus claims the benefit of and/or priority to) U.S. provisional patent application Ser. No. 62/058,658 (filed Oct. 1, 2014).
| Number | Date | Country | |
|---|---|---|---|
| 62058658 | Oct 2014 | US | |
| 61996969 | Oct 2013 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 14520568 | Oct 2014 | US |
| Child | 15989549 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15989549 | May 2018 | US |
| Child | 16683798 | US |
